Overview

Cellular Empire explores the rise of living drugs - from early T-cell biology to engineered cellular therapies that are redefining oncology and regenerative medicine. This volume examines how cell therapy evolved from experimental immunology into a manufacturing-driven, venture-backed industry. It connects the biological foundations of T cells and stem cells with the engineering logic behind chimeric antigen receptor (CAR) platforms, induced pluripotent stem cell (iPSC) technologies, and next-generation delivery systems. Rather than treating cell therapy as a scientific novelty, this book analyzes the full architecture of platform development: biological mechanism, genetic engineering, manufacturing scalability, regulatory realities, solid tumor challenges, and commercialization pathways. It also addresses what it means to become a builder in this field - moving from bench scientist to founder. Designed for clinician-scientists, graduate researchers, translational innovators, and biotech entrepreneurs, Cellular Empire bridges immunology, bioengineering, and capital formation to show how living drugs become global therapeutic platforms. Who This Book Is ForThis volume is written for graduate students, postdoctoral fellows, clinician-scientists, translational research teams, cell therapy engineers, and biotechnology founders seeking a rigorous understanding of engineered cell platforms. It is also appropriate for institutional libraries, cancer centers, and biotech incubators training future innovators. Table of ContentsPart I - The Science of Living Drugs Chapter 1 - The Birth of Living Drugs Chapter 2 - T Cells: Nature's Programmable Soldiers Chapter 3 - Engineering CAR T Cells Chapter 4 - Manufacturing a Cell Therapy Part II - Next-Gen Therapy Chapter 5 - CAR NK and the Rise of Cell Therapies Chapter 6 - iPSCs and Stem Cell Engineering Chapter 7 - Delivery Platforms for Living Drugs Chapter 8 - Cell Therapy in Solid Tumors Part III - The Business & The Builder Chapter 9 - The Business of Cell Therapy Chapter 10 - Becoming a Cell Therapy Founder Appendices Appendix A - Example SBIR Phase I Grant Proposal Appendix B - Example SBIR Phase II Grant Proposal Glossary Index Companies Discussed in this Volume Essential Reading

Full Product Details

9798242195561

Table of Contents

Reviews

Author Information

Tab Content 6

Countries Available